Since the cost to manufacture GLP-1s is modest, higher utilization could lead to better health for the population and more profit for the pharmaceutical companies
This dual mechanism drives its strong efficacy for weight loss (up to 22.5% body weight [1] reduction in the SURMOUNT-1 trial [1] ) and blood sugar control
The 2026 Standards of Care by the American Diabetes Association (ADA) recommend them for adults with type 2 diabetes who also have obesity or overweight, atherosclerotic cardiovascular disease, heart failure, chronic kidney disease or metabolic-associated steatotic liver disease [4]
What treatments actually work for alopecia areata: steroids, PRP, or home remedies
It does not provide dosing advice, dose-change recommendations, or missed-dose medical instructions
This medicine is characterized by minimal reported unfavorable effects